Sign inJoin waitlistJoin the waitlist

Natasha Hunter

Associate Professor, Clinical Research Division, Fred Hutch · University of Washington School of Medicine

Credentials: · · · · ·

History

University of Washington School of Medicine
Present
University of Washington School of Medicine
Present

Johns Hopkins Hospital
2015–2017
Internal Medicine
Beth Israel Deaconess Medical Center
2012–2015
Alpert Medical School
2008–2012
University of Massachusetts, Amherst

Research

Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling
The Pharmacogenomics Journal · 2012 · 33 citations
TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties
Breast Cancer Research and Treatment · 2020 · 22 citations
Resource-Stratified Guideline-Based Cancer Care Should Be a Priority: Historical Context and Examples of Success
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2020 · First of 6 authors · 11 citations

Ben Park
5 papers
Hannah Linden
5 papers
William Gwin
5 papers
Jennifer Specht
4 papers
KC
Karen Cravero
4 papers
Nancy Davidson
4 papers
SV
Shaveta Vinayak
4 papers
AW
Antonio Wolff
2 papers
Daniel Shinn
2 papers
EC
Eric Christenson
2 papers · 1 as a resident
JC
Jenna Canzoniero
2 papers
Joshua Donaldson
2 papers

Clinical trials

A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden
Principal investigator · Not yet recruiting · Phase 2
University of Washington
2026–2030
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
Principal investigator · Recruiting · Phase 2
University of Washington
2025–2028
A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
Principal investigator · Recruiting · Phase 2
University of Washington
2023–2032
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Site PI · Recruiting
Agendia
2017–2037